Literature DB >> 15653572

Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle.

Kimberly A Kelly1, Jennifer R Allport, Andrew Tsourkas, Vivek R Shinde-Patil, Lee Josephson, Ralph Weissleder.   

Abstract

Endothelial vascular adhesion molecule-1 (VCAM-1) is a critical component of the leukocyte-endothelial adhesion cascade, and its strict temporal and spatial regulation make it an ideal target for imaging and therapy. The goal of this study was to develop novel VCAM-1-targeted imaging agents detectable by MRI and fluorescence imaging using phage display-derived peptide sequences and multimodal nanoparticles (NPs). We hypothesized that VCAM-1-mediated cell internalization of phage display-selected peptides could be harnessed as an amplification strategy to chaperone and trap imaging agents inside VCAM-1-expressing cells, thus improving target-to-background ratios. To accomplish our goal, iterative phage display was performed on murine endothelium under physiological flow conditions to identify a family of VCAM-1-mediated cell-internalizing peptides. One specific sequence, containing the VHSPNKK motif that has homology to the alpha-chain of very late antigen (a known ligand for VCAM-1), was shown to bind VCAM-1 and block leukocyte-endothelial interactions. Compared with VCAM-1 monoclonal antibody, the peptide showed 12-fold higher target-to-background ratios. A VHSPNKK-modified magnetofluorescent NP (VNP) showed high affinity for endothelial cells expressing VCAM-1 but surprisingly low affinity for macrophages. In contrast, a control NP without VCAM-1-targeting sequences showed no affinity for endothelial cells. In vivo, VNP successfully identified VCAM-1-expressing endothelial cells in a murine tumor necrosis factor-alpha-induced inflammatory model and colocalized with VCAM-1-expressing cells in atherosclerotic lesions present in cholesterol-fed apolipoprotein E apoE-/- mice. These results indicate that: (1) small peptide sequences can significantly alter targeting of NPs, (2) the used amplification strategy of internalization results in high target-to-background ratios, and (3) this technology is useful for in vivo imaging of endothelial markers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15653572     DOI: 10.1161/01.RES.0000155722.17881.dd

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  147 in total

Review 1.  Endothelial nanomedicine for the treatment of pulmonary disease.

Authors:  Jacob S Brenner; Colin Greineder; Vladimir Shuvaev; Vladimir Muzykantov
Journal:  Expert Opin Drug Deliv       Date:  2014-11-14       Impact factor: 6.648

Review 2.  Targeted probes for cardiovascular MRI.

Authors:  Ritika Uppal; Peter Caravan
Journal:  Future Med Chem       Date:  2010-03       Impact factor: 3.808

Review 3.  Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques.

Authors:  Shann S Yu; Ryan A Ortega; Brendan W Reagan; John A McPherson; Hak-Joon Sung; Todd D Giorgio
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2011-08-10

Review 4.  Molecular characterization of rheumatoid arthritis with magnetic resonance imaging.

Authors:  Jeffrey T Gu; Linda Nguyen; Abhijit J Chaudhari; John D MacKenzie
Journal:  Top Magn Reson Imaging       Date:  2011-04

5.  The cargo of CRPPR-conjugated liposomes crosses the intact murine cardiac endothelium.

Authors:  Hua Zhang; Ning Li; Padmini Sirish; Lisa Mahakian; Elizabeth Ingham; Fitz-Roy Curry; Soichiro Yamada; Nipavan Chiamvimonvat; Katherine W Ferrara
Journal:  J Control Release       Date:  2012-07-07       Impact factor: 9.776

Review 6.  Targeted endothelial nanomedicine for common acute pathological conditions.

Authors:  Vladimir V Shuvaev; Jacob S Brenner; Vladimir R Muzykantov
Journal:  J Control Release       Date:  2015-10-03       Impact factor: 9.776

Review 7.  Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.

Authors:  Yunlu Dai; Can Xu; Xiaolian Sun; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2017-05-18       Impact factor: 54.564

8.  Phage-display-guided nanocarrier targeting to atheroprone vasculature.

Authors:  Lucas H Hofmeister; Sue Hyun Lee; Allison E Norlander; Kim Ramil C Montaniel; Wei Chen; David G Harrison; Hak-Joon Sung
Journal:  ACS Nano       Date:  2015-03-23       Impact factor: 15.881

Review 9.  Molecular imaging in cardiovascular disease: Which methods, which diseases?

Authors:  Jonathan R Lindner; Albert Sinusas
Journal:  J Nucl Cardiol       Date:  2013-12       Impact factor: 5.952

10.  Dextran coated bismuth-iron oxide nanohybrid contrast agents for computed tomography and magnetic resonance imaging.

Authors:  Pratap C Naha; Ajlan Al Zaki; Elizabeth Hecht; Michael Chorny; Peter Chhour; Eric Blankemeyer; Douglas M Yates; Walter R T Witschey; Harold I Litt; Andrew Tsourkas; David P Cormode
Journal:  J Mater Chem B       Date:  2014-12-14       Impact factor: 6.331

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.